Immunogenicity and safety of an investigational quadrivalent measles, mumps, rubella, and varicella vaccine in children aged 4-6 years: A phase II, randomized, multi-country trial. [PDF]
Habib MA +9 more
europepmc +1 more source
Analysis of vaccine adverse events associated with rheumatoid arthritis: A pharmacovigilance study based on the VAERS database. [PDF]
Lu P, Lou M, Qiu Z, Xia R, Shu J, Lu G.
europepmc +1 more source
Reinforcing measles control in the Americas amid mass gatherings: detection, response, and traveler health implications. [PDF]
Pan American Health Organization.
europepmc +1 more source
Mumps resurgence despite MMR: Limitations of current vaccines and the need for new strategies. [PDF]
Vashishtha VM, Upadhyay U.
europepmc +1 more source
Live viral measles-mumps-rubella revaccination and varicella vaccination in children and adolescents with juvenile idiopathic arthritis: a systematic review. [PDF]
Dipasquale RF +3 more
europepmc +1 more source
Congenital rubella hospitalizations in Brazil: interpreting administrative data within the context of rubella elimination. [PDF]
Callado GY +5 more
europepmc +1 more source
Revisiting congenital rubella data in Brazil: caution in interpreting administrative records. [PDF]
Morais CO +3 more
europepmc +1 more source

